Literature DB >> 16163421

[Prevention of community-acquired pneumonia in adults].

Manuel Barros M1, Claudia Cartagena S, Luis Bavestrello F.   

Abstract

Polysaccharide 23 valent pneumococcal vaccine commercially available from 1983 includes 23 serotypes of Streptococcus pneumoniae, representing near 90% of strains involved in invasive pneumococcal disease in immune competent adults. Vaccine confers protection against invasive pneumococcal disease. Immunization is recommended in adults over 65 years old, in patients affected by chronic diseases (cardiopathies, COPD, nephropathies, diabetes mellitus, hepatic cirrhosis, chronic breakage in brain-blood barrier, functional or anatomical asplenia, alcoholism), in immunocompromised hosts, including HIV infection, chemotherapy treatment and hematological malignancies. Influenza vaccine is prepared with particulated antigens, including two influenza A strains and one influenza B strain, selected according to influenza epidemiological worldwide surveillance the year before. On account of continuous antigenic changes (drifts), it is necessary to modify the vaccine antigen's composition yearly. Cost/effectiveness evaluation has confirmed the efficacy of influenza vaccine in reducing morbidity and mortality associated to influenza epidemic and health economical resources involved in patient care. Besides, clinical trials have confirmed that immunization reduces the risk of acquiring pneumonia, of hospitalization and death in elderly people during the influenza epidemic, when vaccine antigenic composition is similar to the circulating strains. Vaccination is recommended annually in healthy adults over 65 years old, in patients with chronic diseases (cardiopathies, COPD, nephropathies, diabetes mellitus, hepatic cirrhosis, chronic breakage of blood-brain barrier, functional or anatomical asplenia, alcoholism). It is also recommended in women who will be in the second or third trimester of pregnancy during the influenza season, in immunocompromised hosts, in institutionalized patients (geriatrics), health care workers, and travelers to geographical areas that are affected by the influenza epidemic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163421     DOI: /S0716-10182005000500009

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  4 in total

1.  Diabetes Mellitus has no Significant Influence on the Prevalence of Antenatal Asymptomatic Bacteriuria.

Authors:  Nissi Priya Mekapogu; Swarnalatha Gundela; Renuka Devi Avula
Journal:  J Clin Diagn Res       Date:  2016-04-01

2.  Infections in patients with diabetes mellitus: A review of pathogenesis.

Authors:  Juliana Casqueiro; Janine Casqueiro; Cresio Alves
Journal:  Indian J Endocrinol Metab       Date:  2012-03

3.  Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain).

Authors:  Antoni Sicras-Mainar; Jordi Ibáñez-Nolla; Isabel Cifuentes; Pablo Guijarro; Ruth Navarro-Artieda; Lorenzo Aguilar
Journal:  BMC Infect Dis       Date:  2012-11-01       Impact factor: 3.090

4.  Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.

Authors:  Saloua Elamari; Imane Motaib; Saad Zbiri; Karim Elaidaoui; Asmaa Chadli; Chafik Elkettani
Journal:  Pan Afr Med J       Date:  2020-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.